FP
PRAH

Foundry Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Foundry Partners’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-42,648
Closed -$3.54M – 422
2020
Q1 		$3.54M Buy
+42,648
New +$4.16M 0.2% 146

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Foundry Partners's PRAH Position: Q2 2020 in Review

Foundry Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 42,648 shares — an estimated $3.54M sold.

Foundry Partners first reported a position in PRAH in Q1 2020 and held it in 1 quarter. The position peaked at $3.54M in Q1 2020. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Foundry Partners reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Foundry Partners sold 42,648 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $3.54M.
  • Foundry Partners first reported a position in PRA Health Sciences, Inc. in Q1 2020 and held it in 1 quarter.
  • Foundry Partners's PRA Health Sciences, Inc. position peaked at $3.54M in Q1 2020.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Foundry Partners's 13F filing for Q2 2020, filed 3 Aug 2020.